Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9175289 Reduced size self-delivering RNAi compounds

Patent 9175289 was granted and assigned to Rxi Pharmaceuticals Corporation on November, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 2 Oct, 2024

"update inverses"

edited on 2 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

Edits on 4 Sep, 2024

"update inverses"

edited on 4 Sep, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12077755 Bioactive conjugates for oligonucleotide delivery

0

Edits on 31 Jul, 2024

"update inverses"

edited on 31 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

0

"update inverses"

edited on 31 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

0

Edits on 4 Jul, 2024

"update inverses"

edited on 4 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12024706 Modified oligonucleotides targeting SNPs

0

Edits on 6 Jun, 2024

"update inverses"

edited on 6 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy

0

Edits on 14 Mar, 2024

"update inverses"

edited on 14 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11926828 Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1

0

Edits on 19 Jan, 2024

"update inverses"

edited on 19 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11872287 Compositions and methods of treating muscle atrophy and myotonic dystrophy

0

Edits on 3 Dec, 2023

"Add patent abstract"

edited on 3 Dec, 2023

Edits made to:

Article (+318 characters)

Article

Patent abstract

The present invention relates to RNAi constructs with minimal double-stranded regions, and their use in gene silencing. RNAi constructs associated with the invention include a double stranded region of 8-14 nucleotides and a variety of chemical modifications, and are highly effective in gene silencing.

Edits on 27 Sep, 2023

"update inverses"

edited on 27 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11767527 Modified oligonucleotides targeting SNPs

Edits on 13 Sep, 2023

"update inverses"

edited on 13 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11753638 Conjugated oligonucleotides

Edits on 2 Aug, 2023

"update inverses"

edited on 2 Aug, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy

0

Edits on 19 Jul, 2023

"update inverses"

edited on 19 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11702659 Optimized anti-FLT1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders

0

Edits on 13 Jul, 2023

"Remove leading 0 from patent number"

edited on 13 Jul, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09175289 Reduced size self-delivering RNAi compounds US Patent 9175289 Reduced size self-delivering RNAi compounds

Infobox

Patent Number

091752890

Patent Number

91752890

Edits on 22 May, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 22 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=091752890

Edits on 6 Apr, 2023

"Entity importer update"

edited on 6 Apr, 2023

Infobox

Is a

0

Patent Applicant

Rxi Pharmaceuticals Corporation

0

Current Assignee

Rxi Pharmaceuticals Corporation

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

091752890

Date of Patent

November 3, 2015

0

Patent Application Number

142789000

Date Filed

May 15, 2014

0

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=091752890

Patent Primary Examiner

Jennifer McDonald

0

Edits on 8 Jun, 2022

"Entity importer update"

edited on 8 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=09175289

Edits on 4 Jan, 2022

"Created via: Entity Importer"

created this topic on 4 Jan, 2022

Edits made to:

Infobox (+9 properties)

‌

US Patent 09175289 Reduced size self-delivering RNAi compounds

Infobox

Is a

Patent applicant

Rxi Pharmaceuticals Corporation

Current assignee

Rxi Pharmaceuticals Corporation

Patent jurisdiction

United States Patent and Trademark Office

Patent number

09175289

Date of patent

November 3, 2015

Patent application number

14278900

Date Filed

May 15, 2014

Patent primary examiner

Jennifer McDonald

Find more entities like US Patent 9175289 Reduced size self-delivering RNAi compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.